Cerebral arteriopathies

Aneesh B Singhal MD (Dr. Singhal of Harvard Medical School received consutling fees from Biogen, Dock Technologies, and Medicolegal for consulting, owns stock in Biogen, and receives research support from Boehringer Ingelheim.)
Steven R Levine MD, editor. (Dr. Levine of the SUNY Health Science Center at Brooklyn has received honorariums from Genentech for service on a scientific advisory committee and a research grant from Genentech as a principal investigator.)
Originally released December 18, 2001; last updated June 14, 2016; expires June 14, 2019

Overview

In this article, the author presents an approach to the diagnosis and management of cerebral arteriopathies. Several important entities are briefly reviewed, including carotid and vertebral arterial dissection, moyamoya disease, reversible cerebral vasoconstriction syndromes, primary angiitis of the central nervous system, dolichoectasia, sickle cell disease, CADASIL, Fabry disease, and selected genetic and inherited arteriopathies.

Key points

 

• Cerebral arteriopathies are a diverse group of disorders requiring a high index of suspicion and reliance on clinical and imaging clues for diagnosis.

 

• Small-vessel arteriopathies may not be revealed on cerebral angiography.

 

• Accurate diagnosis is important because individual cerebral arteriopathies have unique management and prognostic implications.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.